OverviewText1

• Professor Danny Liew has an honorary appointment at the Department of Medicine (Royal Melbourne Hospital), and is the current Chair in Clinical Outcomes Research at the School of Public Health and Preventive Medicine at Monash University.
  
  He was previously the Chair in Clinical Epidemiology at the University of Melbourne, and inaugural Director of the Melbourne EpiCentre (Collaborative Centre for Clinical Epidemiology, Biostatistics and Health Services Research) based at the Royal Melbourne Hospital. 
  
  Professor Liew's research interests lie in clinical epidemiology (including clinical trials), health services research and health economics, especially in the areas of chronic diseases and therapeutics.   

Selected publications

• 2019

  • Journal Articles

    • Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate 2019
    • Impact of scribes on emergency medicine doctors' productivity and patient throughput: multicentre randomised trial.  British Medical Journal.  364. 2019
    • Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies 2019
    • Prescription of physical activity in the management of high blood pressure in Australian general practices.  Journal of Human Hypertension.  33. 2019
    • Productivity burden of smoking in Australia: A life table modelling study.  Tobacco Control.  28. 2019
    • The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective.  International Journal of Cardiology.  285. 2019
    • Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial.  Journal of Thoracic and Cardiovascular Surgery.  157. 2019

  • Journal Articles Refereed

    • A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.  Cancer Discovery.  9. 2019
    • A prospective study of the incidence of drug-induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane.  Alimentary Pharmacology and Therapeutics.  49. 2019
    • Clinical decision support improves quality of care in patients with ulcerative colitis.  Alimentary Pharmacology and Therapeutics.  49. 2019
    • Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes.  Scientific Reports.  9. 2019
    • First seizure presentations in adults: Beyond assessment and treatment.  Journal of Neurology, Neurosurgery and Psychiatry.  2019
    • Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.  Genetics in Medicine.  2019
    • Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.  British Journal of Clinical Pharmacology.  85. 2019
    • Predictors of statin use among older adults: A nationwide cross-sectional study.  Journal of Clinical Lipidology.  13. 2019
    • The role of dihydrosphingolipids in disease.  Cellular and Molecular Life Sciences.  76. 2019

  • Journal Articles Unrefereed Letters or Notes

    • Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practice 2019
    • Determining the cost of first-ever seizures: A narrative review and future directions.  Epilepsy and Behavior.  90. 2019

• 2018

  • Journal Articles

    • Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016 2018
    • Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry.  Heart, Lung and Circulation.  2018

  • Journal Articles Refereed

    • A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data 2018
    • A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged >= 65 Years.  Journal of Gerontology Series A - Biological Sciences and Medical Sciences.  73. 2018
    • Additional structured physical activity does not improve walking in older people (> 60 years) undergoing inpatient rehabilitation: a randomised trial.  Journal of Physiotherapy.  64. 2018
    • Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis.  Journal of Gerontology Series A - Biological Sciences and Medical Sciences.  73. 2018
    • Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.  Journal of Crohn's and Colitis.  12. 2018
    • Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).  Cardiovascular Diabetology.  17. 2018
    • Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study.  European Journal of Clinical Microbiology & Infectious Diseases.  37. 2018
    • Cost of gastroenteritis in Australia: A healthcare perspective.  PLoS One.  13. 2018
    • Cost-Effectiveness of Rena Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.  American Journal of Hypertension.  31. 2018
    • Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.  Genetics in Medicine.  20. 2018
    • Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective.  International Journal of Cardiology.  270. 2018
    • Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study.  European Journal of Clinical Pharmacology.  74. 2018
    • Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry 2018
    • Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke.  International Journal of Environmental Research and Public Health.  15. 2018
    • Evaluation of the Effectiveness of a Phone Based Care Coordination Pilot on Hospital Utilisation and Costs for Patients With Chest Pain.  Heart, Lung and Circulation.  27. 2018
    • Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort.  Internal Medicine Journal.  48. 2018
    • Forecasting the future burden of opioids for osteoarthritis.  Osteoarthritis and Cartilage.  26. 2018
    • GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.  BMJ Open.  8. 2018
    • Is establishing a specialist back pain assessment and management service in primary care a safe and effective model? Twelve-month results from the Back pain Assessment Clinic (BAC) prospective cohort pilot study.  BMJ Open.  8. 2018
    • Modeling the economic outcomes of immuno-oncology drugs: Alternative model frameworks to capture clinical outcomes 2018
    • Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age 2018
    • Observational studies and their utility for practice.  Australian Prescriber.  41. 2018
    • Patterns of statin use and long-term adherence and persistence among older adults with diabetes.  Journal of Diabetes.  10. 2018
    • Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis.  Arthritis Care & Research.  70. 2018
    • Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.  Journal of Viral Hepatitis.  25. 2018
    • Resting heart rate, temporal changes in resting heart rate, and overall and cause-specific mortality.  Heart.  104. 2018
    • Risk factor management in a contemporary Australian population at increased cardiovascular disease risk.  Internal Medicine Journal.  48. 2018
    • Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel.  Alimentary Pharmacology and Therapeutics.  48. 2018
    • The Challenges of Stem Cell Therapy in Myocardial Infarction and Heart Failure and the Potential Strategies to Improve the Outcomes 2018
    • The Productivity Burden of Diabetes at a Population Level.  Diabetes Care.  41. 2018
    • The productivity burden of diabetes at a population level.  Diabetes Care.  41. 2018
    • Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study.  JAMA Neurology.  75. 2018
    • Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM).  Diabetes Research and Clinical Practice.  142. 2018

  • Journal Articles Unrefereed Letters or Notes

    • LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk.  Clinical Pharmacology and Therapeutics.  104. 2018

  • Other Refereed Contribution to Refereed Journals

    • Benefit of targeted, pharmacist-led education for junior doctors in reducing prescription writing errors – a controlled trial.  Journal of Pharmacy Practice and Research.  48. 2018
    • Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.  Systematic Reviews.  7. 2018
    • Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.  Value in Health.  21. 2018
    • Mind the Gap: Mismatches Between Clinicians and Patients in Heart Failure Medication Management 2018
    • Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia 2018
    • Reinitiation of Statin Therapy After Discontinuation: A Meta-analysis.  Mayo Clinic Proceedings.  93. 2018
    • Renal safety of short-term empiric gentamicin therapy in aged patients.  Australasian Journal on Ageing.  37. 2018
    • Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort.  OpenHeart.  5. 2018
    • The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.  International Journal of Cardiology.  267. 2018
    • What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review.  Clinical Microbiology and Infection.  24. 2018

• 2017

  • Journal Articles Refereed

    • A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocol.  BMC Geriatrics.  17. 2017
    • Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development.  Future Cardiology.  13. 2017
    • Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study.  Journal of Hypertension.  35. 2017
    • Cardiac fibrosis in the ageing heart: Contributors and mechanisms.  Clinical and Experimental Pharmacology and Physiology.  44. 2017
    • Caring for people with dementia in hospital: findings from a survey to identify barriers and facilitators to implementing best practice dementia care.  International Psychogeriatrics.  29. 2017
    • Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective.  Applied Health Economics and Health Policy.  15. 2017
    • Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease.  Scandinavian Journal of Gastroenterology.  52. 2017
    • Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.  Journal of Gastroenterology and Hepatology.  32. 2017
    • Health care costs associated with Australian tertiary inflammatory bowel disease care.  Scandinavian Journal of Gastroenterology.  52. 2017
    • Injury trends from envenoming in Australia, 2000-2013.  Internal Medicine Journal.  47. 2017
    • Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?.  Medical Mycology.  55. 2017
    • Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.  Pharmacoeconomics.  35. 2017
    • Poorer outcomes and greater healthcare costs for hospitalised older people with dementia and delirium: a retrospective cohort study.  International Journal of Geriatric Psychiatry.  32. 2017
    • RESPOND: a programme to prevent secondary falls in older people presenting to the emergency department with a fall: protocol for an economic evaluation.  Injury Prevention.  23. 2017
    • SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace.  Australian Health Review.  41. 2017
    • Serologic antibodies in relation to outcome in postoperative Crohn's disease.  Journal of Gastroenterology and Hepatology.  32. 2017
    • Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.  British Medical Journal.  356. 2017
    • The functions and roles of questioning during nursing handovers in specialty settings: an ethnographic study.  Contemporary Nurse.  53. 2017

  • Journal Articles Unrefereed Letters or Notes

    • AUTHOR RESPONSE: EXCESS MORTALITY AND HOSPITALIZED MORBIDITY IN NEWLY TREATED EPILEPSY PATIENTS.  Neurology.  88. 2017
    • Adverse Drug Reactions Associated With Cholinesterase Inhibitorsd-Sequence Symmetry Analyses Using Prescription Claims Data.  Journal of the American Medical Directors Association.  18. 2017
    • Antihypertensive medication use and breast cancer risk Reply.  Journal of Hypertension.  35. 2017
    • Author response: Excess mortality & hospitalized morbidity in newly treated epilepsy patients.  Neurology.  88. 2017
    • NEONATAL VITAMIN D SUPPLEMENTATION.  Journal of Paediatrics and Child Health.  53. 2017

  • Other Refereed Contribution to Refereed Journals

    • Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study.  European Journal of Preventive Cardiology.  24. 2017
    • Incidence of fatal snake bite in Australia: A coronial based retrospective study (2000-2016).  Toxicon.  131. 2017
    • Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review.  JMIR Research Protocols.  6. 2017
    • Vitamin D in newborns. A randomised controlled trial comparing daily and single oral bolus vitamin D in infants.  Journal of Paediatrics and Child Health.  53. 2017

• 2016

  • Journal Articles Refereed

    • A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia.  Value in Health.  19. 2016
    • An economic evaluation of the costs of training a medical scribe to work in Emergency Medicine.  Emergency Medicine Journal.  33. 2016
    • Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.  Pathology.  48. 2016
    • Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.  Journal of Gastroenterology and Hepatology.  31. 2016
    • Comparison of Fecal Inflammatory Markers in Crohn's Disease.  Inflammatory Bowel Diseases.  22. 2016
    • Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective.  Medicine (Baltimore): analytical reviews of general medicine, neurology, psychiatry, dermatology and pediatrics.  95. 2016
    • Cost-effectiveness of Crohn's disease post-operative care.  World Journal of Gastroenterology.  22. 2016
    • Evaluating antimicrobial therapy: How reliable are remote assessors? 2016
    • Excess mortality and hospitalized morbidity in newly treated epilepsy patients.  Neurology.  87. 2016
    • Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.  Scandinavian Journal of Clinical and Laboratory Investigation.  76. 2016
    • Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.  BMJ Open.  6. 2016
    • Phase 4 Studies in Heart Failure - What is Done and What is Needed? 2016
    • Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment.  Neurology.  86. 2016
    • Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.  Neurosurgery.  79. 2016
    • Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.  Journal of Clinical Pathology.  69. 2016
    • The "four-hour target' and the impact on Australian metropolitan acute surgical services.  ANZ Journal of Surgery.  86. 2016
    • The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis.  BMC Health Services Research.  16. 2016
    • The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice 2016

  • Journal Articles Unrefereed Letters or Notes

    • RESPOND: A programme to prevent secondary falls in older people presenting to the emergency department with a fall: Protocol for an economic evaluation.  Injury Prevention.  2016

  • Other Refereed Contribution to Refereed Journals

    • Reference ranges of peripheral blood lymphoid subsets by 10-colour flow cytometry based on 69 healthy adults from Australia.  Pathology.  48. 2016

• 2015

  • Journal Articles

    • Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.  European Journal of Preventive Cardiology.  22. 2015
    • PSA doubling time as a screening test to predict bone scan positivity.  Journal of Clinical Urology.  8. 2015

  • Journal Articles Refereed

    • Barriers and enablers affecting patient engagement in managing medications within specialty hospital settings.  Health Expectations.  18. 2015
    • Benefits and resource implications of family meetings for hospitalized palliative care patients: research protocol.  BMC Palliative Care.  14. 2015
    • Bridging the Osteoporosis Treatment Gap: Performance and Cost-Effectiveness of a Fracture Liaison Service.  Journal of Clinical Densitometry.  18. 2015
    • Clinical effectiveness of a silicone foam dressing for the prevention of heel pressure ulcers in critically ill patients: Border II Trial.  Journal of Wound Care.  24. 2015
    • Crohn's disease management after intestinal resection: a randomised trial.  The Lancet.  385. 2015
    • Direct Hospital Cost Determinants Following Hip and Knee Arthroplasty.  Arthritis Care & Research.  67. 2015
    • Effect of Intestinal Resection on Quality of Life in Crohn's Disease.  Journal of Crohn's and Colitis.  9. 2015
    • Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.  Alimentary Pharmacology and Therapeutics.  42. 2015
    • Evaluating the effects of increasing physical activity to optimize rehabilitation outcomes in hospitalized older adults (MOVE Trial): study protocol for a randomized controlled trial.  Trials.  16. 2015
    • Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study.  Australian Health Review.  39. 2015
    • Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery.  Gastroenterology.  148. 2015
    • Medication communication during handover interactions in specialty practice settings.  Journal of Clinical Nursing.  24. 2015
    • Outcomes of decompressive craniectomy in patients after traumatic brain injury.  Critical Care and Resuscitation.  17. 2015
    • Overview of shorthand medical glossary (OMG*) study.  Internal Medicine Journal.  45. 2015
    • Pharmacists' Interprofessional Communication About Medications in Specialty Hospital Settings.  Health Communication.  30. 2015
    • Predictors of disability worsening in clinically isolated syndrome.  Annals of Clinical and Translational Neurology.  2. 2015
    • Subtrochanteric fracture: The effect of cerclage wire on fracture reduction and outcome.  Injury: International Journal of the Care of the Injured.  46. 2015
    • The cost-benefit of using soft silicone multilayered foam dressings to prevent sacral and heel pressure ulcers in trauma and critically ill patients: a within-trial analysis of the Border Trial.  International Wound Journal.  12. 2015

• 2014

  • Journal Articles

    • COST UTILITY OF DIABETES DRUGS USING HBA1C AS A DIRECT PREDICTOR FOR QUALITY OF LIFE, DIABETES COMPLICATIONS AND MORTALITY.  Value in Health.  17. 2014

  • Journal Articles Refereed

    • Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.  Journal of Hypertension.  32. 2014
    • An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.  Diabetes Research and Clinical Practice.  106. 2014
    • An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol.  BMC Family Practice.  15. 2014
    • Attitudes towards antimicrobial stewardship: Results from a large private hospital in Australia.  Healthcare Infection.  19. 2014
    • Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol.  Implementation Science.  9. 2014
    • Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.  European Journal of Preventive Cardiology.  21. 2014
    • Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia.  Journal of Clinical Lipidology.  8. 2014
    • Clearing emergency departments and clogging wards: National Emergency Access Target and the law of unintended consequences.  Emergency Medicine Australasia.  2014
    • Cost effectiveness of eplerenone in patients with chronic heart failure.  American Journal of Cardiovascular Drugs.  14. 2014
    • Does warfarin-related intracerebral haemorrhage lead to higher costs of management?.  Clinical Neurology and Neurosurgery.  126. 2014
    • Drug-induced hepatotoxicity: Incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.  Liver International.  34. 2014
    • Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.  Liver International.  34. 2014
    • Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions.  Neurology.  83. 2014
    • Effects of patient-, environment- and medication-related factors on high-alert medication incidents.  International Journal for Quality in Health Care.  26. 2014
    • Fingolimod after natalizumab and the risk of short term relapse.  Neurology.  82. 2014
    • Overview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial data.  British Journal of Clinical Pharmacology.  77. 2014
    • Performance of the Assessment of Quality of Life measure in people with hip and knee joint disease and implications for research and clinical use..  Arthritis Care & Research.  66. 2014
    • Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors.  Transfusion.  54. 2014
    • Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data.  International Journal of Cardiology.  175. 2014
    • Quantifying the excess cost and resource utilisation for patients with complications associated with elective knee arthroscopy: a retrospective cohort study..  The Knee.  21. 2014
    • Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.  PLoS One.  9. 2014
    • Risk of relapse phenotype recurrence in multiple sclerosis.  Multiple Sclerosis.  20. 2014
    • Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease.  Quality of Life Research.  23. 2014
    • Using periodic point-prevalence surveys to assess appropriateness of antimicrobial prescribing in Australian private hospitals.  Internal Medicine Journal.  44. 2014

• 2013

  • Journal Articles Refereed

    • A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia.  International Journal of Cardiology.  167. 2013
    • Comparison of Health-Related Quality of Life, work status, and health care utilization and costs according to hip and knee joint disease severity: Results from a national Australian study .  Physical Therapy.  93. 2013
    • Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients.  Journal of Thoracic Oncology.  8. 2013
    • Cost analysis of debridement and retention for management of prosthetic joint infection.  Clinical Microbiology and Infection.  19. 2013
    • Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes.  Clinical Therapeutics.  35. 2013
    • Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian Stroke Center..  Stroke.  44. 2013
    • Current and emerging antiviral treatments for hepatitis C infection.  British Journal of Clinical Pharmacology.  75. 2013
    • Diabetes Prevention and Treatment Strategies: Are we doing enough?.  Diabetes Care.  36. 2013
    • Do Patients Who Take Part in Stroke Research Differ from Non-Participants? Implications for Generalizability of Results.  Cerebrovascular Diseases.  35. 2013
    • Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience.  Australasian Psychiatry.  21. 2013
    • Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis.  Internal Medicine Journal.  43. 2013
    • Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC).  Mycoses.  56. 2013
    • Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement And Coaching for Health (PEACH) pragmatic cluster randomised controlled trial.  British Medical Journal.  347. 2013
    • Enterococcal bacteraemia: Factors influencing mortality, length of stay and costs of hospitalization.  Clinical Microbiology and Infection.  19. 2013
    • Impact of emergency access targets on admissions to general medicine: a retrospective cohort study.  Internal Medicine Journal.  43. 2013
    • Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study.  Heart.  99. 2013
    • Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.  Cardiovascular Therapeutics.  31. 2013
    • Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes.  Internal Medicine Journal.  43. 2013
    • N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF).  European Journal of Heart Failure.  15. 2013
    • NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF).  International Journal of Cardiology.  169. 2013
    • Outcomes and Excess Costs among Patients with Cardiovascular Disease.  Heart, Lung & Circulation.  22. 2013
    • Overview of pharmacoeconomic modelling methods.  British Journal of Clinical Pharmacology.  75. 2013
    • Predicting the Impact of Polypill Use in a Metabolic Syndrome Population: An Effectiveness and Cost-Effectiveness Analysis 2013
    • Radial probe EBUS versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: an economic analysis.  European Respiratory Journal.  41. 2013
    • Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.  Brain.  136. 2013
    • The "cost" of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice.  BMC Family Practice.  14. 2013
    • The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.  PLoS One.  8. 2013
    • The Impact of Lost Therapeutic Benefit (LTB) in High-Risk Hypertensive Patients: 2-Year Follow-Up Data from the Australian REACH Registry.  Cardiovascular Therapeutics.  31. 2013
    • The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.  Arthritis Research & Therapy.  15. 2013

  • Journal Articles Unrefereed Letters or Notes

    • Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.  Gut.  62. 2013
    • The elephant in the room of hypertension treatment reply.  Internal Medicine Journal.  43. 2013

  • Conference Proceedings

    • Do patients who take part in stroke research differ from non-participants? Implications for generalizability of results.  Cerebrovascular Diseases. 2013
    • Predicting bone scan positivity: the utility of PSA doubling time versus absolute PSA levels.  BJU International. 2013
    • Recovery Trajectories in Acute Non-fatal Stroke.  Stroke. 2013
    • Seasonal, Circaseptan and Diurnal Variations in Stroke Onset, Severity and Costs: Findings from the Royal Melbourne Hospital Stroke Registry 2004-2011.  Stroke. 2013
    • The Health and Economic Consequences Of Delay In Starting Disease-Modifying Anti-Rheumatic Drugs In Australian Patients With Early Rheumatoid Arthritis.  Arthritis and Rheumatism. 2013
    • Time To Institution Of Disease Modifying Anti-Rheumatic Drugs In Australian Patients With Early Rheumatoid Arthritis..  Arthritis and Rheumatism. 2013

• 2012

  • Journal Articles

    • Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis (vol 66, pg 1906, 2011).  Journal of Antimicrobial Chemotherapy.  67. 2012
    • Inhibition by fatty acids during fermentation of pre-treated waste activated sludge.  Journal of Biotechnology.  159. 2012

  • Journal Articles Refereed

    • A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels.  Asia Pacific Journal of Clinical Oncology.  8. 2012
    • Changes to the statin prescribing policy in Belgium: potential impact in clinical and economic terms 2012
    • Controlled clinical trial of a self-management program for people with mental illness in an adult mental health service – the Optimal Health Program (OHP).  Australian Health Review.  36. 2012
    • Cost-minimisation analysis of midazolam versus droperidol for acute agitation in the emergency department.  Journal of Pharmacy Practice and Research.  42. 2012
    • Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations..  International Journal of Evidence-based Healthcare.  10. 2012
    • Interventions to reduce medication errors in adult intensive care: a systematic review.  British Journal of Clinical Pharmacology.  74. 2012
    • N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.  Arthritis Research & Therapy.  14. 2012
    • National nursing registration in Australia: A way forward for nurse practitioner endorsement.  Journal of the American Academy of Nurse Practitioners.  24. 2012
    • Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.  Mycoses.  55. 2012
    • Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands.  Netherlands Heart Journal.  20. 2012
    • Statin prescribing in Europe: A comparison of differences and potential impact on health outcomes.  Primary Care Cardiovascular Journal.  5. 2012
    • Substitution Monotherapy With Levetiracetam vs Older Antiepileptic Drugs: A Randomized Comparative Trial.  Archives of Neurology.  69. 2012
    • The association between radiographic severity and pre-operative function in patients undergoing primary knee replacement for osteoarthritis.  The Knee.  19. 2012
    • The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model.  British Medical Journal.  344. 2012
    • The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it?.  Expert Review of Pharmacoeconomics and Outcomes Research.  12. 2012
    • Working with CALD groups: testing the feasibility of an intervention to improve medication self-management in people with kidney disease, diabetes, and cardiovascular disease.  Renal Society of Australasia Journal.  8. 2012

  • Other Refereed Contribution to Refereed Journals

    • Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.  Medical Journal of Australia.  196. 2012

  • Conference Proceedings

    • Early Versus Delayed Initiation of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis..  Arthritis and Rheumatism. 2012
    • Statin prescription in Europe: the potential conflict between clinical guidelines and healthcare policies.  European Heart Journal. 2012
    • The Impact of Severe Hip and Knee Joint Disease On Paid and Unpaid Work Participation in Australia..  Arthritis and Rheumatism. 2012

  • Conference Papers Refereed

    • Predicting Blood Loss and Transfusion Requirement in Patients Undergoing Surgery for Musculoskeletal Tumors 2012
    • SERVICE UTILIZATION, PREDICTORS AND COSTS AMONG HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE: USING REAL WORLD DATA FROM THE AUSTRALIAN REACH REGISTRY 2012

• 2011

  • Journal Articles

    • Care of severe head injury patients in the Sarawak General Hospital: Intensive care unit versus general ward.  Medical Journal of Malaysia.  66. 2011

  • Journal Articles Refereed

    • Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths.  Australian and New Zealand Journal of Public Health.  35. 2011
    • Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry.  Clinical Therapeutics.  33. 2011
    • Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.  Journal of Antimicrobial Chemotherapy.  66. 2011
    • Economic burden of obesity in primary total knee arthroplasty.  Arthritis Care & Research.  63. 2011
    • Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study.  BMC Public Health.  13. 2011
    • Identification of urinary biomarkers for age-related macular degeneration.  Investigative Ophthalmology and Visual Science.  52. 2011
    • Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow up.  Australasian Journal of Dermatology.  52. 2011
    • The effect of joint aspiration and corticosteroid injections in osteoarthritis of the knee.  International Journal of Rheumatic Diseases.  14. 2011
    • Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation.  European Journal of Cardiovascular Prevention & Rehabilitation.  18. 2011

  • Conference Proceedings

    • KONQUEST: KEPPRA VERSUS OLDER AEDS AND NEUROPSYCHIATRIC, NEUROCOGNITIVE AND QUALITY OF LIFE OUTCOMES IN TREATMENT OF EPILEPSY AS SUBSTITUTION MONOTHERAPY.  Epilepsia. 2011
    • VOLATILE ANAESTHESIA IS A SIGNIFICANT CAUSE OF POST-OPERATIVE HEPATITIS.  Hepatology. 2011

• 2010

  • Journal Articles Refereed

    • Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer: A Decision Tree Sensitivity Analysis.  Journal of Thoracic Oncology.  5. 2010
    • Economic implications of obesity among people with atherothrombotic disease.  International Journal of Obesity.  34. 2010
    • Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors.  Journal of Epidemiology and Community Health.  64. 2010
    • Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.  Journal of Antimicrobial Chemotherapy.  65. 2010
    • Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry 2010
    • The Economic Implications of Treating Atherothrombotic Disease in Australia, From the Government Perspective.  Clinical Therapeutics.  32. 2010
    • The Effect of Nightshift on Emergency Registrars’ Clinical Skills.  Emergency Medicine Australasia.  22. 2010
    • The impact of obesity on weight change and outcomes at 12 months in patients undergoing total hip arthroplasty.  Medical Journal of Australia.  193. 2010
    • The impact of pre-operative obesity on weight change and outcome in total knee replacement.  Journal of Bone and Joint Surgery, British Volume.  92-B. 2010
    • The impact of preoperative obesity on weight change and outcome in total knee replacement: A prospective study of 529 consecutive patients (Journal of Bone and Joint Surgery (Br) (2010) 92-B, (513-520)).  Journal of Bone and Joint Surgery, British Volume.  92. 2010

  • Conference Proceedings

    • LOST THERAPEUTIC BENEFIT (LTB) IN HIGH RISK PATIENTS MANAGED FOR HYPERTENSION IN AUSTRALIAN GENERAL PRACTICE.  Hypertension. 2010
    • URINARY BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION.  Clinical and Experimental Ophthalmology. 2010

• 2009

  • Journal Articles Refereed

    • Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.  Journal of Antimicrobial Chemotherapy.  63. 2009
    • Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis.  Journal of Hypertension.  27. 2009
    • Drug Treatment and Cost of Cardiovascular Disease in Australia.  Cardiovascular Therapeutics.  27. 2009
    • Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia.  Journal of Antimicrobial Chemotherapy.  63. 2009
    • Potential survival gains in the treatment of myocardial infarction.  Heart.  95. 2009
    • Results of a Markov Model Analysis to Assess the Cost-Effectiveness of Statin Therapy for the Primary Prevention of Cardiovascular Disease in Korea: The Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.  Clinical Therapeutics.  31. 2009
    • Results of a Markov Model Analysis to Assess the Cost-Effectiveness of a Single Tablet of Fixed-Dose Amlodipine and Atorvastatin for the Primary Prevention of Cardiovascular Disease in Korea.  Clinical Therapeutics.  31. 2009
    • The COACH Program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications - Two years follow-up.  Heart, Lung & Circulation.  18. 2009
    • The Role of Traditional Cardiavascular Risk Factors Among Patients with Rheumatoid Arthritis.  Journal of Rheumatology.  36. 2009

  • Journal Articles Unrefereed Letters or Notes

    • Obesity in total hip replacement.  Journal of Bone and Joint Surgery, British Volume.  91. 2009

  • Other Refereed Contribution to Refereed Journals

    • Clozapine-induced cardiotoxicity: a clinical update.  Medical Journal of Australia.  190. 2009
    • The Relationship Between Reduction in Low-Density Lipoprotein Cholesterol by Statins and Reduction in Risk of Cardiovascular Outcomes: An Updated Meta-Analysis.  Clinical Therapeutics.  31. 2009

  • Conference Proceedings

    • MEAN ANNUAL COSTS OF ANTIHYPERTENSIVE MEDICATIONS AMONG PATIENTS WITH, OR AT RISK OF ATHEROTHROMBOSIS-DATA FROM THE REDUCTION OF ATHEROTHROMBOSIS FOR CONTINUED HEATH (REACH) REGISTRY.  Hypertension. 2009
    • MODELLING THE IMPACT OF ACHIEVING RISK FACTOR TARGETS ON CVD EVENTS IN A COMMUNITY-BASED STUDY.  Hypertension. 2009

• 2008

  • Journal Articles

    • Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis.  Cochrane Database of Systematic Reviews.  2008

  • Journal Articles Refereed

    • Interrater Reliability of the Australasian Triage Scale for mental health patients.  Emergency Medicine Australasia.  20. 2008
    • Lifetime risk and projected population prevalence of diabetes.  Diabetologia.  51. 2008
    • Predicting the effectiveness of prevention: a role for epidemiological modeling.  The Journal of Primary Prevention.  29. 2008

  • Conference Proceedings

    • Do COX-2 Inhibitors Raise Blood Pressure More Than Non-selective NSAIDs and Placebo?: An Updated Meta-analysis of Clinical Trials Involving > 130,000 Participants.  Circulation. 2008
    • Mean annual costs of antihypertensive therapy among patients at risk of atherothrombosis - data from the Reduction of Atherothrombosis for Continued Health (REACH) registry.  Journal of Hypertension. 2008
    • Potential Survival Gains in the Treatment of Myocardial Infarction in Australia.  Circulation. 2008

• 2007

  • Journal Articles

    • A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin.  Clinical Therapeutics.  29. 2007
    • Clozapine-associated myocarditis - A review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.  Drug Safety.  30. 2007

  • Conference Proceedings

    • Blood pressure is inadequately treated in Australia especially among males and those under sixty five years.  Circulation. 2007
    • Differences in cardiovascular risk factor profiles between patients with and without rheumatoid arthritis.  Circulation. 2007
    • Statin under-treatment and its predictors: Results from a large community survey.  Journal of the American College of Cardiology. 2007
    • The cardiovascular disease prevention model: A model that predicts future incidences of cardiovascular disease in any given population and undertakes cost-effectiveness analyses of primary preventive interventions.  Journal of the American College of Cardiology. 2007

• 2006

  • Journal Articles

    • A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease.  European Journal of Cardiovascular Prevention & Rehabilitation.  13. 2006
    • Blood pressure effects of COX-2 inhibitors.  Journal of Cardiovascular Pharmacology.  47. 2006
    • Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?.  Journal of Hypertension.  24. 2006

• 2005

  • Journal Articles

    • COX-2 inhibitors and the risk for hypertension 2005
    • Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≥70.  British Medical Journal.  330. 2005
    • Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.  Archives of Internal Medicine.  165. 2005
    • The cardiovascular safety of celecoxib..  Future Cardiology.  1. 2005

  • Conference Proceedings

    • Modeled effects of the American Heart Association's guidelines on low-dose aspirin for the primary prevention of cardiovascular disease numbers needed to treat and harm.  Circulation. 2005

• 2004

  • Journal Articles

    • A feeling in the waters: Diagnosis of heart failure using urinary natriuretic peptides.  Clinical Science.  106. 2004
    • Cardiovascular effects of selective cyclooxygenase-2 inhibitors.  Expert Review of Cardiovascular Therapy.  2. 2004
    • Eplerenone in the treatment of chronic heart failure.  Expert Review of Cardiovascular Therapy.  2. 2004
    • Utility of B-Type Natriuretic Peptide As A Screen for Left Ventricular Dysfunction in Patients with Diabetes 9 (multiple letters).  Diabetes Care.  27. 2004

• 2003

  • Journal Articles

    • Accuracy of the Australian national death index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with pravastatin in ischaemic disease (LIPID) study.  Australian and New Zealand Journal of Public Health.  27. 2003
    • Aldosterone receptor antagonists for hypertension: What do they offer?.  Drugs.  63. 2003
    • Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.  Current Opinion in Investigational Drugs.  4. 2003
    • Emergency department length of stay independently predicts excess inpatient length of stay.  Medical Journal of Australia.  179. 2003
    • Emergency department length of stay independently predicts excess inpatient length of stay.  Medical Journal of Australia.  179. 2003
    • Eplerenone Pharmacia.  Current Opinion in Investigational Drugs.  4. 2003
    • New and emerging drug therapies for the management of acute heart failure.  Internal Medicine Journal.  33. 2003
    • New developments in the pharmacological treatment of chronic heart failure.  Expert Opinion on Investigational Drugs.  12. 2003
    • Novel biomedical risk markers for cardiovascular disease 2003
    • Recent advances in the management of chronic heart failure..  Australian Family Physician.  32. 2003
    • Should patients with chronic heart failure be treated with "statins"? 2003

  • Journal Articles Unrefereed

    • Recent advances in the management of chronic heart failure.  Australian Family Physician.  32. 2003

• 2002

  • Journal Articles

    • Diastolic heart failure in the elderly.  Medicine Today.  3. 2002
    • The role of aldosterone receptor blockade in the management of cardiovascular disease..  Current Opinion in Investigational Drugs.  3. 2002

  • Journal Articles Unrefereed

    • Epidemiological modelling (including economic modelling) and its role in preventive drug therapy.  Medical Journal of Australia.  177. 2002

• 2001

  • Journal Articles

    • A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk.  European Journal of Cardiovascular Prevention & Rehabilitation.  8. 2001
    • Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria.  Medical Journal of Australia.  175. 2001

Investigator on

• Contract

  • First Seizure Assessment and Management  administered by Computing and Information Systems 2018 - 2019
  • Costs of arthritis economic impact study  awarded by ARTHRITIS AUSTRALIA 2015 - 2016
  • Cost-effectiveness of novel treatments for ovarian cancer  awarded by ASTRAZENECA PTY LTD 2014 - 2016
  • THE USE OF STRUCTURAL, PERFUSION AND RESTING STATE MRI TECHNIQUES AS A BIOMARKER TO INVESTIGATE THE CEREBRAL IMPACT OF A SITTING TIME REDUCTION AND PHYSICAL ACTIVITY INTERVENTION IN OLDER ADULTS WITH TYPE 2 DIABETES: A FEASIBILITY PILOT STUDY  awarded by THE AUSTRALIAN NATIONAL UNIVERSITY 2014 - 2015
  • Cost-Effectiveness of Smoking Cessation Therapy in Australia  awarded by PFIZER AUST PTY LTD 2013
  • Cost-effectiveness of antimicrobials for gram-positive hospital infections  awarded by PFIZER AUST PTY LTD 2013
  • Cost-effectiveness of novel anticoagulants for stroke prevention in AF  awarded by PFIZER AUST PTY LTD 2013
  • PREDICTORS OF STROKE OUTCOMES AND THEIR ASSOCIATED COSTS  administered by Medicine - Royal Melbourne Hospital 2012 - 2013
  • COST-EFFECTIVENESS OF VARENICLINE FOR SMOKING CESSATION IN AUSTRALIA  awarded by PFIZER AUST PTY LTD 2012
  • Cost-effectiveness of apixaban for stroke prevention in atrial fibrillation in Australia.  awarded by PFIZER AUST PTY LTD 2012

• Grant

  • MODELLING OF CLINIC AND AMBULATORY BLOOD PRESSURE ON CARDIOVASULAR RISK AND OUTCOMES (Project Grants)  administered by Medicine - Royal Melbourne Hospital 2014 - 2015
  • Towards improved communication for medication safety: addressing the complexities of managing medications in hospitalised children (Discovery Projects)  awarded by AUST RESEARCH COUNCIL 2013 - 2016
  • THE ARTHROPLASTY AND BARIATRIC SURGERY (ABS) STUDY (Project Grants)  awarded by NHMRC 2012 - 2016
  • Time to DMARD treatment for patients with newly diagnosed RA in Australia: an updated analysis and cost estimate (Clinical Trial Grant)  awarded by ABBOTT AUSTRALASIA PTY LTD 2012 - 2015
  • Is MS treatment effective long-term? (Project Grants)  awarded by NHMRC 2012 - 2014
  • TELEHEALTH FACILITATION OF DIABETES AND CARDIOVASCULAR CARE IN AUSTRALIA (Partnership Projects)  awarded by NHMRC 2011 - 2015
  • Effective communication and improved patient safety: addressing the complexities of managing high risk medications in metropolitan and regional hospitals (Discovery Projects)  awarded by AUST RESEARCH COUNCIL 2010 - 2014
  • NT- PROBNP AND THE IDENTIFICATION AND TREATMENT OF STRUCTURAL HEART DISEASE AND HEART FAILURE IN HIGH RISK INDIVIDUALS (Project Grants)  awarded by ST VINCENTS INSTITUTE OF MEDICAL RESEARCH 2009 - 2013
  • Epidemiological modelling of cardiovascular disease and diabetes in Australia. (Postdoctoral Research Fellowship)  awarded by NATIONAL HEART FOUNDATION 2008
  • IMPROVING THE QUALITY AND VALUE OF HEALTHCARE DELIVERY (Melbourne Vanderbilt University Dyason Fellowships)  awarded by UNIVERSITY OF MELBOURNE

Additional Grant Information

Education and training

• PhD, Monash University 2005
• GradCertHealthEco, Monash University 2001
• MBBS (Hons), Monash University 1994
• BMedSc, Monash University 1994

Awards and honors

• Fellow of the Royal Australasian College of Physicians, 2002

Available for supervision

• Y